Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea

NCT00098384 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

INDIV

Sponsor class

Conditions

Diarrhea

Interventions

DRUG: rifaximin

Sponsor

DuPont, Hurbert L., MD

Collaborators

[object Object]
[object Object]